MeSH D011183 - postoperative complications
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D011183:Â
Postoperative complications
D000069290:Incisional hernia
0 Companies
0 Drugs
Success rate
D000071257:Emergence delirium
0 Companies
0 Drugs
Success rate
D000072656:Breast cancer lymphedema
0 Companies
0 Drugs
Success rate
D000079690:Postoperative cognitive complications
0 Companies
0 Drugs
Success rate
D000343:Afferent loop syndrome
0 Companies
0 Drugs
Success rate
D006083:Vascular graft occlusion
D008305:Malignant hyperthermia
D010149:Postoperative pain
D011178:Postgastrectomy syndromes
0 Companies
0 Drugs
Success rate
D011185:Postpericardiotomy syndrome
0 Companies
0 Drugs
Success rate
D011475:Prosthesis failure
0 Companies
0 Drugs
Success rate
D012773:Surgical shock
0 Companies
0 Drugs
Success rate
D013529:Surgical wound dehiscence
0 Companies
0 Drugs
Success rate
D013530:Surgical wound infection
D015427:Reperfusion injury
0 Companies
0 Drugs
Success rate
D016459:Prosthesis-related infections
0 Companies
0 Drugs
Success rate
D017562:Postcholecystectomy syndrome
0 Companies
0 Drugs
Success rate
D019106:Postoperative hemorrhage
0 Companies
0 Drugs
Success rate
D020250:Postoperative nausea and vomiting
D055111:Failed back surgery syndrome
0 Companies
0 Drugs
Success rate
D055191:Delayed emergence from anesthesia
0 Companies
0 Drugs
Success rate
D055954:Corneal endothelial cell loss
0 Companies
0 Drugs
Success rate
D056124:Slit ventricle syndrome
0 Companies
0 Drugs
Success rate
D056987:Vasoplegia
0 Companies
0 Drugs
Success rate
D057868:Anastomotic leak
0 Companies
0 Drugs
Success rate
D058686:Coronary-subclavian steal syndrome
0 Companies
0 Drugs
Success rate
D000094123:Low anterior resection syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Heparin | Lipo-hepin |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Warfarin | Panwarfin |  | 1982-01-01 |  |  |
| Alkem Laboratories | Vancomycin | Vancomycin |  | 2022-11-14 |  |  |
| Allergan | Heparin | Heparin |  | 1995-10-10 |  |  |
| Codeine, Promethazine | Promethazine Codeine |  | 1984-10-31 |  |  | |
| Vancomycin | Vancomycin |  | 2012-04-09 |  |  | |
| Warfarin | Warfarin |  | 1982-08-17 |  |  | |
| Amneal Pharmaceuticals | Codeine, Promethazine | Promethazine Codeine |  | 2013-04-24 |  |  |
| Dextromethorphan, Promethazine | Promethazine Dextromethorphan |  | 2011-02-08 |  |  | |
| Phenylephrine, Codeine, Promethazine | Promethazine Hydrochloride,phenylephrine W/codeine |  | 2015-08-26 |  |  | |
| Phenylephrine, Promethazine | Promethazine Phenylephrine |  | 2009-08-25 |  |  | |
| Warfarin | Warfarin |  | 2013-03-04 |  |  | |
| Vancomycin | Vancomycin |  | 2023-06-23 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
83%5/6
Phase 2
52%13/25
Phase 3
43%20/46
Approved: 11Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use